BA
The Boeing Company
BA has the edge over SPCB overall, supported by stronger fundamentals and lower modeled downside.
SPCB
SuperCom Ltd.
SPCB offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
SPCB Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Stable | |
| Weak |
SPCB's revenue is currently healthy, and its profitability and cash flow are stable, but its balance sheet is weak.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over SPCB in the historical PE scenario, which offers more potential upside but is not a forecast.
SPCB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 11x | $6.66 | — |
| Cheap | 16x | $2.50 | -62% |
| Fair | 18x | $2.91 | -56% |
| Expensive | 38x | $6.05 | -9.1% |
| Current | 42x | $6.66 | — |
Historical ranges are pointers, not guarantees.
SPCB's PE is 42x, but its earnings don't support one, so it isn't a reliable read right now.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
BA has the edge over SPCB on the outlook, with more favorable profitability expectations.
SPCB Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for SPCB, but weaker profitability. However, they disagree widely on these estimates.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has the edge over SPCB in the latest year-over-year earnings comparison.
SPCB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.59 | +272% |
| Q2 2026 | $0.16 | -79% |
SPCB earned $0.16 per share over the past year, down 79% from the year before.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over SPCB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
SPCB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $8.1M | +13% |
| Q1 2026 | $7.6M | +8% |
| Q4 2025 | $7.5M | +13% |
| Q3 2025 | $6.2M | -9.9% |
| Q2 2025 | $7.1M | -5.4% |
| Q1 2025 | $7M | +2.9% |
| Q4 2024 | $6.6M | +17% |
| Q3 2024 | $6.9M | +2% |
SPCB's revenue has picked up after two years of holding roughly level: $8M last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 14% | -2.5 points |
| Q1 2026 | 17% | -0.6 points |
| Q4 2025 | -12% | +2.6 points |
| Q3 2025 | 12% | +11 points |
| Q2 2025 | 17% | +12 points |
| Q1 2025 | 17% | +6.8 points |
| Q4 2024 | -14% | +30 points |
| Q3 2024 | 1.8% | -11 points |
SPCB has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over SPCB on cash flow, with more consistent year-over-year improvement.
SPCB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | $0 |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$666K |
| Q3 2025 | $0 | +$666K |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$666K | -$666K |
| Q3 2024 | -$666K | -$666K |
SPCB's free cash flow was $0 over the past year, against −$1M the year before.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has the edge over SPCB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
SPCB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +14K shares |
| 1 year | +59% | +2.1M shares |
SPCB has 6M diluted shares, up 59% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $24,500 |
| Q3 2024 | $24,500 |
SPCB hasn't bought back shares in the past year.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA has the edge over SPCB on leverage, with a lower net debt burden relative to earnings.
SPCB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 5.0x | High |
| Q1 2026 | 3.2x | Elevated |
| Q4 2025 | 1.7x | Healthy |
| Q3 2025 | 1.0x | Healthy |
| Q2 2025 | 1.1x | Healthy |
| Q1 2025 | 0.9x | Very low |
| Q4 2024 | 5.0x | High |
| Q3 2024 | 5.4x | High |
SPCB's net debt is about 5.0 years of its operating earnings (EBITDA), up from 1.1 years a year ago.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
SPCB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 17.9 | Oversold |
SPCB's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA has the edge over SPCB on valuation relative to its sector.
SPCB PE vs Industrials Sector
| Metric | SPCB | Sector median | Relative |
|---|---|---|---|
| PE | 42x | 24x | 73% above |
| PE % | 93 | 58 | 35 pts above |
SPCB is trading at 42x earnings, a 73% premium to the Industrials sector's median of 24x, though its earnings don't support one.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
SPCB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.88 | 25% below |
| 20 week MA | $9.99 | 33% below |
| 50 week MA | $9.64 | 31% below |
| 100 week MA | $9.45 | 30% below |
| 200 week MA | $10.7 | 38% below |
SPCB is in a downtrend: it's below all five of its weekly moving averages, and 38% below its 200-week average.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has the edge over SPCB on returns for 2026, with the stronger performance.
SPCB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $129.0 | $212.0 | +64% |
| 2021 | $212.0 | $106.2 | -50% |
| 2022 | $106.2 | $40.0 | -62% |
| 2023 | $40.0 | $7.72 | -81% |
| 2024 | $7.72 | $3.84 | -50% |
| 2025 | $3.84 | $9.35 | +143% |
| 2026 YTD | $9.35 | $6.66 | -29% |
SPCB's yearly returns have swung widely, from +143% in 2025 to −81% in 2023. It's down 29% so far in 2026.